Article Details
Retrieved on: 2021-07-08 06:43:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca plc (LON:AZN) announced that an asthma treatment developed with Amgen has been granted priority review in the US. Tezepelumab ...
Article found on: www.proactiveinvestors.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here